Antiviral Drugs Market – Global Industry Analysis, Market Size Estimation, Growth Forecast By Type (Antiretroviral Drugs, Anti Herpes Virus Drugs, Anti Influenza Drugs, Interferons, Vaccines and Others), Mechanism of Action (Reverse Transcriptase (RT) Inhibitors, Uncoating Inhibitors, Protease Inhibitors, Fusion Inhibitors and Others) and Regions, 2017 – 2025

Report Formats: pdf file iconexcel file iconPPT File Image  |  Report Category: Healthcare


Global Antiviral Drugs Market - Analysis

The antiviral drugs market report offers a complete analysis and forecast of the market on global and regional level. The analysis of the market dynamics which includes market drivers and restraints, pricing signals, demand, competitive landscape, opportunities in the emerging markets is depicted in this research report. The study of market dynamics such as factors impacting the growth assists to comprehend the current market trends in the global antiviral drugs industry. The report projects the market size and share along with profiles of leading companies operating in the global market.

 

Key Pointers of Antiviral Drugs Market Report
Antiviral Drugs Market Report Highlights
 
Antiviral Drugs Markets Growth Influencing Factors
Factors Affecting the Growth of the Antiviral Drugs Market
 

HOW IS THE MARKET SEGMENTED

By Term Segments
By Type Antiretroviral Drugs, Anti-Herpes Virus Drugs, Anti-Influenza Drugs, Interferons, Vaccines and Others
By Mechanism of Action Reverse Transcriptase (RT) Inhibitors such as nucleoside RT inhibitors, non-nucleoside RT inhibitors, and nucleotide RT inhibitors; Uncoating Inhibitors, Protease Inhibitors, Fusion Inhibitors and Others
By Regions Asia Pacific, North America, Middle East & Africa (MEA), Europe and Latin America

 

WHO ARE THE MAJOR PLAYERS IN THIS MARKET

Headquarters Corporations
The U.S. Merck & Co., Inc., Bristol-Myers Squibb, Johnson & Johnson and others
England GlaxoSmithKline Plc and others
Switzerland F. Hoffmann-La Roche AG and others

 


PURCHASE FULL REPORT | PRICING PLANS COMPARISON

 

DATA PACK
US$ 3,500
Restricted to Single User
Delivered in the Microsoft Excel Format
10% Free Customization
Report Update will be charged accordingly
Analyst Support will be billed separately
SINGLE USER
US$ 5,000
Restricted to Single User
Delivered in Excel/PDF/PPT Format
15% Free Customization
Free Report Update (Within 6 Months)
Free Post Delivery Analyst Support
MULTI USER
US$ 7,000
No User Restrictions
Delivered in Excel/PDF/PPT Format
15% Free Customization
Free Report Update (Within 6 Months)
Free Post Delivery Analyst Support

Introduction

The global antiviral drugs market is expected to grow at a moderate pace during the forecast period 2017 to 2025. In the antiviral drugs market report, the market is segmented based on type, mechanism of action and regions. Antiviral drugs or antiviral pharmaceuticals are those medications which are utilized for prevention or treatment of diseases caused by viruses. These drugs are a type of antimicrobials and are mostly used for inhibiting the development or spread of a viral disease. Antiviral drugs are not similar to viricides since the latter is used for killing the viruses, while the former only inhibits the growth of viruses. Prescription antiviral drugs include ganciclovir, acyclovir, zidovudine, amantadine and oseltamivir among others. The growth in acquired immunodeficiency syndrome (AIDS) patients globally have been resulting in growing demand for antiretroviral drugs. Also, the four major classes of direct-acting antivirals are increasingly being used for the treatment of Hepatitis-C patients. The antiviral drugs market size and volume is primarily being driven by the increasing growth of virus-related diseases and patient pool globally.

 

Report Overview

Aspect Details
Base Year of Estimation 2016
Value Estimation Year 2017
Forecast Period 2017 - 2025
Market Segmentations By Type, Mechanism of Action, Regions
Regional Scope Asia Pacific, North America, Middle East & Africa (MEA), Europe and Latin America
Report Coverage Market Dynamics, Segmentation Overview and Competitive Landscape of the market

 

Market Dynamics

As per the studies conducted by World Health Organization (WHO) and Organization, around 36.7 million people had AIDS in 2015 while a significantly large number of people are unaware of whether they have AIDS or not. Such huge numbers of patients are required to take antiretroviral drugs for limiting the effects of AIDS. This, in turn, has been promoting the growth of the market for antiviral drugs.

The rise in diseases caused by new types of viruses has also been positively impacting the demand for antiviral drugs. Viruses such as Zika virus, Nipah virus, Ebola virus and Hendra virus are some of the new types of viruses which have been infecting a large population of people globally. Since these are newer types of viruses, the traditional antiviral drug therapies often are ineffective. This has led to high demand for newer types of antiviral treatments, thus growing the antiviral drugs market size.

While most common antiviral treatments have fewer side effects, antiretroviral drugs, however, has several side effects, coupled with the high price of branded treatment regimens. This, in turn, has been inhibiting the growth of the antiviral drugs market. However, WHO estimates that almost 70% of all AIDS patients are present in sub-Saharan Africa and also quite a less number of people has proper access to antiretroviral treatments. Market penetration of antiretroviral drugs in this region can be expected to offer high growth opportunities for the antiviral drugs market.

 

Segmentation Overview

The antiviral drugs market, based on type, can be segmented into antiretroviral drugs, anti-herpes virus drugs, anti-influenza drugs, interferons, vaccines and others. Antiretroviral drugs segment was the largest segment in 2016, owing to their higher price and huge patient pool. On the basis of the mechanism of action, the antiviral drugs market is segmented as reverse transcriptase (RT) inhibitors, uncoating inhibitors, protease inhibitors, fusion inhibitors and others. RT inhibitors have been further segmented into nucleoside RT inhibitors, non-nucleoside RT inhibitors, and nucleotide RT inhibitors. RT inhibitors were the largest segment in 2016 and include drugs such as zalcitabine, didanosine, delaviridine, nevirapine and tenofovir among others.

By geography, the market has been segmented into Asia-Pacific, North America, Middle East & Africa (MEA), Europe and Latin America. Owing to higher rates of research & development and growing number of initiatives for developing newer antiviral drugs, North America commanded the largest market share by revenue in 2016.

 

Competitive Landscape

The antiviral drugs industry study lists some of the major companies operating in this market. They are Merck & Co., Inc. (The U.S.), GlaxoSmithKline Plc (England), Bristol-Myers Squibb (The U.S.), Johnson & Johnson (The U.S.), and F. Hoffmann-La Roche AG (Switzerland) among others.

Get Free Table of Contents (TOC) for Market Research Reports. We guarantee report delivery within 10 Days & offer 15% free customization. This also includes 60 minutes free analyst support post report delivery.
The privacy and security of your shared information are very important to us. Our website is secure and your personal details are safe.

This website is secure and safe. Read our Privacy Policy.

Get Free Samples for Market Research Reports. The privacy and security of your shared information are very important to us. Our website is secure and your personal details are safe.

CLIENT REVIEWS

★★★★☆
4 5 1
Factor & Equilibrium delivered report as promised and on time. They worked hard and reply to our queries was fast. Working with them was a good experience.

TELL US HOW YOU LIKE OUR SERVICE

Your Name
Email
Rating
Review Content